Clinical Trials Browser

OTHER × Tiragolumab × Thoracic × Clear all

NCT06713798 2026-03-23

INDIGO

Phase 2 Withdrawn

Lung Neoplasms

NCT04958811 2026-01-26

Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC

Phase 2 Active not recruiting

Lung Neoplasms

NCT05746481 2026-01-22

Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases

Phase 2 Terminated

3 enrolled 12 charts

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT03977467 2025-08-27

Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor

Phase 2 Completed

46 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT05825625 2025-05-23

NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05259319 2023-10-17

IMMUNOs-SBRT

Phase 1 Unknown

GenitourinaryHead & NeckThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Head and Neck Neoplasms, Neoplasms

NCT05034055 2021-09-05

SKYROCKET

Phase 2 Unknown

Carcinoma, Non-Small-Cell Lung